A. A. Feltrin

Triple therapy in chronic hepatitis C: initial series in a public health program in the South of Brazil.

C. Tovo, C. B. Fonseca, P. Almeida, 2015, Arquivos de gastroenterologia.

Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients.

C. Tovo, D. Kliemann, A. A. de Mattos, 2016, Journal of infection in developing countries.

Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir

L. Noblat, L. R. Pereira, S. F. G. Chachá, 2018, Revista do Instituto de Medicina Tropical de Sao Paulo.

Effectiveness and safety of protease inhibitors for the hepatitis C treatment in a hospital of South Brazil: real life data

M. R. Farias, C. Blatt, A. A. Feltrin, 2018 .

IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS

C. Tovo, A. A. de Mattos, A. A. Feltrin, 2016, Revista do Instituto de Medicina Tropical de Sao Paulo.

Treatment of hepatitis C with peginterferon and ribavirin in a public health program.

P. Picon, C. Tovo, A. A. de Mattos, 2009, Hepato-gastroenterology.